Value20202021202220232024TTMSelling/general/admin expenses4.72 M5.78 M6.85 M5.32 M5.8 M—Research & development5.82 M6.39 M7.68 M6.67 M7.19 M—Operating income4.83 M5 M12.68 M4.96 M1.39 M—Non-Operating Income, Total——————Interest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses——————Unusual income/expense——————Pretax income5.15 M6.42 M13.03 M3.95 M3.46 M—Equity in earnings——————Taxes237 K43 K315 K251 K538 K—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations5.38 M6.46 M13.35 M4.2 M2.92 M—Discontinued operations——————Net income5.38 M6.46 M13.35 M4.2 M2.92 M—Dilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders——————Basic earnings per share (Basic EPS)——————Diluted earnings per share (Diluted EPS)——————Average basic shares outstanding——————Diluted shares outstanding——————EBITDA-4.74 M-4.89 M-12.58 M-4.85 M1.59 M—EBIT-4.83 M-5 M-12.68 M-4.96 M1.39 M—Cost of revenue5.06 M6.6 M7.13 M8.31 M10.44 M—Other cost of goods sold——————Depreciation & amortization (cash flow)87 K107 K99 K108 K201 K—
BrainsWay Ltd - American Depositary Shares
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.